Search results
Found 10547 matches for
A team of international researchers, including scientists at the MRC Molecular Haematology Unit, report promising results from a phase I clinical trial of Enasidenib, a novel drug that may help patients suffering from Acute Myeloid Leukaemia.
Anindita Roy
Group Leaders MRC MHU
MRCPCH FRCPath PhD Anindita Roy - Professor of Paediatric Haematology
Asger Jakobsen
MRC MHU Researchers
BMBCh, MRCP, DPhil Asger Jakobsen - Postdoctoral Clinical Research Fellow
Sten Eirik W. Jacobsen
Group Leaders MRC MHU
PhD, M.D. Sten Eirik W. Jacobsen - Bass Professor of Developmental and Stem Cell Biology
Jim Hughes
Centre for Computational Biology Group Leaders MRC MHU
Jim Hughes - Professor of Gene Regulation
Natalina Elliott
MRC MHU Researchers
PhD-Cancer Biology, Vanderbilt University; BS-Recombinant Genetics & Chemistry, Western Kentucky University Natalina Elliott - Postdoctoral Researcher
Tatjana Sauka-Spengler
Group Leaders
Tatjana Sauka-Spengler - Professor of Developmental Genomics and Gene Regulation
David Jackson
Group Leaders MRC TIDU
B.A. (Natural Sciences), Ph.D. (Biochemistry) David Jackson - Professor of Human Immunology